Research Article| Volume 40, ISSUE 4, P399-412, October 1989

Pharmacokinetics and pharmacodynamics of a new long-acting androgen ester : Maintenance of physiological androgen levels for 4 months after a single injection

      This paper is only available as a PDF. To read, Please Download here.


      The pharmacokinetics and pharmacodynamics of testosterone trans-4-n-butylcyclohexyl carboxylate (Code name: 20 Aet-1), a new long-acting androgen ester, were evaluated in castrated adult rhesus monkeys and compared with those of testosterone enanthate (TE). A single intramuscular injection of 40 mg of 20 Aet-1 returned serum testosterone (T) to within or close to the diurnal physiological range for 80–136 days. In contrast, a similar dose of TE increased serum T to supraphysiological levels and the response evoked was of short duration. The ratio of T to dihydrotestosterone (T/DHT) ratio in monkeys treated with 20 Aet-1 was comparable to that found in control animals while in TE-treated animals, it was highly elevated. Serum estradiol (E2) elevation by 20 Aet-1 was also of smaller magnitude compared to TE. 20-Aet-1 suppressed LH levels from day 5 until day 115. The levels of LH on day 115 were 45.8% lower compared to the levels on day 13 post-castration. TE suppressed LH levels from day 1–7 post-injection. The values on day 7 were 76.6% lower compared to values on day 13 post-castration. Thus, TE-induced suppression of LH was of shorter duration, but of greater magnitude compared to the effect caused by 20 Aet-1. Similarly, FSH was suppressed for a longer duration (days 21–74) by 20 Aet-1 than by TE. The results indicate that the new testosterone ester has highly favourable pharmaco-kinetic properties and may prove to be the androgen of choice for supplementation therapy in contraceptive regimens.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bajaj J.S.
        • Madan R.
        Regulation of male fertility.
        in: Diczfalusy E. Diczfalusy A. 8 Aufl. Research on the Regulation of Human Fertility. Vol.2. 1983: 729-767 (Copenhagen)
        • Nieschlag E.
        • Cuppers H.J.
        • Wiegelmann W.
        • Wickings E.J.
        Bioavailability and LH suppressing effect of different testosterone preparations in normal and hypogonadal men.
        Hormone Res. 1976; 7: 138-145
        • Sokol R.Z.
        • Palacios A.
        • Campfield L.A.
        • Saul C.
        • Swerdloff R.S.
        Comparison of kinetics of injectable testosterone in eugonadal and hypogonadal men.
        Fertil Steril. 1982; 37: 425-430
        • Schulte-Beerbuhl M.
        • Nieschlag E.
        Comparison of testosterone, dihydrotestosterone, luteinisng hormone and follicle stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate.
        Fertil Steril. 1980; 33: 201-203
        • Schurmeyer T.
        • Nieschlag E.
        Comparative pharmaco-kinetics of testosterone enanthate and testosterone cyclohexane-carboxylate as assessed by serum and saliva testosterone in normal men.
        Int J Androl. 1984; 7: 181-187
      1. Bialy, G. Personal Communication (1985).

        • Weinbauer G.F.
        • Marshall G.R.
        • Nieschlag E.
        New injectable testosterone ester maintains serum testosterone of castrated monkeys in the normal range for four months.
        Acta Endocrinol. 1986; 113: 128-132
        • Sufi S.B.
        • Donaldson A.
        • Jeffcoate S.L.
        • WHO Special Programme of Research, Development and Research Training in Human Reproduction
        Programme for the Provision of Matched Assay Reagents for the Radioimmunoassay of Hormones in Reproductive Physiology.
        • Sjoberg S.
        • de le Torre B.
        • Hedman M.
        • Falkay G.
        • Diczfalusy E.
        Circadian variations in systemic hormone levels in healthy men.
        J Endocrinol Invest. 1979; 2: 131-137
        • Brenner P.F.
        • Guerrero R.
        • Cekan Z.
        • Diczfalusy E.
        Radioimmunoassay of six steroids in human plasma.
        Steroids. 1973; 22: 775-794
        • Khan S.A.
        • Froysa B.
        • Diczfalusy E.
        Biological and immunological characterisation of purified follicle stimulating hormone preparations from monkey pituitaries.
        J Med Primatol. 1984; 13: 269-282
        • Khan S.A.
        • Lindberg M.
        • Diczfalusy E.
        Hetero-logous radioimmunoassay of monkey luteinising hormone. A critical assessment.
        J Med Primatol. 1984; 13: 191-204